high-content screening
Cytek Biosciences Prices $200M Initial Public Offering
The company, which has developed novel technology for single-cell analyses, is selling an aggregate of 16,749,330 shares of its common stock.
Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
Livecyte enables users to automatically characterize growth, morphology, and motility of large populations of cells in 96-well plates.
AMRI, PerkinElmer to Collaborate on Drug Discovery
The partners will provide drug discovery services, expertise, and infrastructure in a new AMRI center located in the Buffalo Medical Innovation and Commercialization Hub.
Sanford-Burnham, Pfizer Team in Hunt for Insulin Resistance Targets
NEW YORK (GenomeWeb News) – The Sanford-Burnham Medical Research Institute said today that its investigators will collaborate with Pfizer to identify therapeutic targets for use in preventing and treating complications related to obesity and diabetes.
Cenix, Debiopharm Ink Biomarker ID Deal
NEW YORK (GenomeWeb News) – Cenix BioScience and Debiopharm Group today announced a research agreement to use Cenix's technology in support of Debiopharm's drug development efforts.
Oct 23, 2012
Dec 7, 2011
Sony, Maven Reach Consumables Development Deal
Nov 25, 2011
Cytoo Raises $10M in Series C Round
Oct 13, 2011
May 13, 2011
Molecular Devices Distributing De Novo Software
Aug 5, 2010